No connection

Search Results

ITOC

BEARISH
$0.28 Live
iTonic Holdings Ltd. · NASDAQ
$0.25 52W Range $32.0

At a glance

Key valuation, profitability, growth, and risk metrics.

Updated Apr 12, 2026
Market cap
$6.92M
P/E
N/A
ROE
-71.2%
Profit margin
N/A
Debt/Equity
0.02
Dividend yield
N/A

AI Analysis

AI-powered fundamental assessment

Confidence
95%
ITOC presents a high-risk profile characterized by a Piotroski F-Score of 4/9, indicating only marginal stability amidst a catastrophic price collapse. While the company shows strong top-line revenue growth (91.60%) and exceptional short-term liquidity (Current Ratio 8.83), these are completely overshadowed by an unsustainable operating margin of -681.94%. The stock has plummeted from a 52-week high of $32.00 to $0.28, reflecting a total loss of investor confidence and a severe technical breakdown.

Key Strengths

Strong YoY revenue growth of 91.60%
Very high liquidity with a Current Ratio of 8.83
Low leverage with a Debt/Equity ratio of 0.02
Healthy Gross Margin of 62.59%
Trading below book value (P/B 0.78)

Key Risks

Extreme operational inefficiency (Operating Margin -681.94%)
Catastrophic price depreciation (99% drop from 52-week high)
Negative ROE (-71.25%) and ROA (-40.98%)
Excessive Price/Sales ratio (13.23) for a non-profitable entity
Complete lack of analyst coverage and institutional support

Performance Snowflake

Multi-dimensional analysis across 5 key categories

Overall
23
Weak
Value
20
Future
40
Past
5
Health
50
Dividend
0
AI Verdict
Speculative / High Risk
Key drivers: Extreme operating losses, Price collapse, Micro-cap volatility
Confidence
90%
Value
20/100

Ref P/E, PEG, Graham Number

Positives
  • P/B ratio below 1.0
Watchpoints
  • P/S ratio of 13.23 is prohibitively high for 0% profit margin
  • No Graham Number available due to negative earnings
Future
40/100

Ref Growth rates

Positives
  • Rapid revenue growth (91.6%)
Watchpoints
  • Burn rate is unsustainable
  • No path to profitability evident in margins
Past
5/100

Ref Historical trends

Positives
No standout positives identified.
Watchpoints
  • 1Y Change of -90.8%
  • 5Y Change of -92.6%
Health
50/100

Ref Altman Z-Score, Piotroski F-Score

Positives
  • Very low debt
  • Strong current and quick ratios
Watchpoints
  • Piotroski F-Score of 4/9 is only marginally stable
  • Severe negative ROE
Dividend
0/100

Ref Yield, Payout

Positives
No standout positives identified.
Watchpoints
  • No dividend history
  • 0% payout ratio

Stock Price & Analyst Targets

Real-time price movements and analyst price targets

Current Price
$0.28

Multi-Horizon Performance vs Peers

Price momentum across 5Y → 1W horizons for ITOC and closest competitors.

Updated 2026-04-10
ITO
iTonic Holdings Ltd.
Primary
5Y
-92.6%
3Y
-92.6%
1Y
-90.8%
6M
-60.0%
1M
-17.4%
1W
-8.2%
BRT
BioRestorative Therapies, Inc.
Peer
5Y
-99.5%
3Y
-93.0%
1Y
-85.2%
6M
-84.5%
1M
+8.1%
1W
-7.9%
BMR
Biomerica, Inc.
Peer
5Y
-95.7%
3Y
-88.5%
1Y
-46.5%
6M
-34.3%
1M
-3.0%
1W
0.0%
BIA
bioAffinity Technologies, Inc.
Peer
5Y
-99.5%
3Y
-98.4%
1Y
-92.9%
6M
-86.5%
1M
+9.8%
1W
-1.5%
ALU
Allurion Technologies Inc.
Peer
5Y
-99.8%
3Y
-99.8%
1Y
-84.6%
6M
-75.5%
1M
-69.7%
1W
-11.7%

Positive values indicate cumulative gains over the specified period. Comparables pulled from the same sector to highlight whether momentum is stock-specific or industry-wide.

Historical Performance Trends

Long-term financial metrics and growth patterns

Revenue & Net Income

Profit & Operating Margins

Return on Equity (ROE)

Quarterly Revenue Growth

Historical data shows last 12 quarters (3 years)

Valuation Metrics

Key valuation ratios and pricing indicators

P/E Ratio
N/A
Forward P/E
N/A
PEG Ratio
N/A
P/B Ratio
0.78
P/S Ratio
13.23
EV/Revenue
7.64
EV/EBITDA
-0.77
Market Cap
$6.92M

Profitability

Profit margins and return metrics

Profit Margin N/A
Operating Margin -681.94%
Gross Margin 62.59%
ROE -71.25%
ROA -40.98%

Growth

Revenue and earnings growth rates

Revenue Growth +91.6%
Earnings Growth N/A
Q/Q Revenue Growth N/A
Q/Q Earnings Growth N/A

Financial Health

Balance sheet strength and liquidity metrics

Debt/Equity
0.02
Low debt
Current Ratio
8.83
Strong
Quick Ratio
6.95
Excellent
Cash/Share
$0.17

Financial Statement Flow

Interactive flow visualization showing how money moves through the company Q4 2025

Total Assets
$0.0B
Liabilities
$0.0B
Equity
$0.0B
Debt/Equity
0.16x

Healthcare Sector Comparison

Comparing ITOC against 264 companies in the Healthcare sector (20 bullish, 87 neutral, 157 bearish)
Return on Equity (ROE)
-71.25%
This Stock
vs
-46.09%
Sector Avg
+54.6% (Excellent)
Debt to Equity
0.02
This Stock
vs
4.1
Sector Avg
-99.6% (Less Debt)
Revenue Growth
91.6%
This Stock
vs
88.16%
Sector Avg
+3.9% (Growing)
Current Ratio
8.83
This Stock
vs
3.58
Sector Avg
+146.9% (Stronger)

Similar Companies

Peer comparison within the same industry

Past News Coverage

Recent headlines mentioning ITOC from our newsroom.

Newest → oldest
TradingGPT V2 Copilot
Fundamentals • Valuation • Risk
Hi! I'm your fundamentals copilot.

Ask me to:
• Summarize the business quality
• Review valuation and multiples
• Highlight risks and red flags
• Explain growth and margin trends
Home
Terminal
AI
Markets
Profile